# Materialise (MTLS) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/MTLS
## Company Profile
- Ticker: MTLS
- Exchange: NASDAQ
- Sector: Biopharma
- Location: Belgium
## Stock Data
- Close: 6.8 USD
- Market cap: 401404950.96 USD
- Last updated: 2026-08-12
## Business Overview
### Additive-Manufacturing Technology
Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models.
### Medical Solutions
The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other 3D-printed devices used by clinicians and medical-device companies.
### Manufacturing Software
Materialise sells software used to prepare, manage and optimize additive-manufacturing workflows across industrial and healthcare customers.
### Production Services
The company also manufactures prototypes and end-use parts for customers that require additive-manufacturing capacity without operating their own production infrastructure.
## Why The Stock Is Moving

The latest monitored company update is “Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- Materialise's catalysts are 3D-printing adoption, orthopedic software, and medical-application demand. The company benefits when clinical and industrial demand both stay healthy.

## Recent News
- 2026-08-13 10:45 EST — [Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026](https://biopharmsignal.com/news/MTLS/materialise-nv-to-report-second-quarter-and-half-year-2026-earnings-on-thursday--154ffa6e) — Source: Materialise
- 2026-07-20 20:00 EST — [MATERIALISE  AANDELENINKOOPPROGRAMMA](https://biopharmsignal.com/news/MTLS/materialise-aandeleninkoopprogramma-dfec872e) — Source: Materialise
- 2026-07-20 20:00 EST — [MATERIALISE SHARE-BUY BACK PROGRAM](https://biopharmsignal.com/news/MTLS/materialise-share-buy-back-program-7a2516b1) — Source: Materialise
- 2026-07-01 20:05 EST — [Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions](https://biopharmsignal.com/news/MTLS/annual-general-meeting-of-materialise-nv-held-at-the-registered-office-of-the-co-5541f657) — Source: Materialise
- 2026-05-16 02:00 EST — [Materialise houdt jaarlijkse aandeelhoudersvergadering op 16 juni 2026](https://biopharmsignal.com/news/MTLS/materialise-houdt-jaarlijkse-aandeelhoudersvergadering-op-16-juni-2026) — Source: Materialise